| シミズ ユウコ
            SHIMIZU Yuuko 清水 優子 所属 医学部 医学科(東京女子医科大学病院) 職種 教授 | |
| 論文種別 | 原著 | 
| 言語種別 | 英語 | 
| 査読の有無 | 査読あり | 
| 表題 | The MG-QOL15 Japanese version: validation and associations with clinical factors. | 
| 掲載誌名 | 正式名:Muscle & nerve 略 称:Muscle Nerve ISSNコード:10974598/0148639X | 
| 掲載区分 | 国外 | 
| 巻・号・頁 | 46(2),pp.166-173 | 
| 著者・共著者 | Masuda Masayuki, Utsugisawa Kimiaki, Suzuki Shigeaki, Nagane Yuriko, Kabasawa Chiaki, Suzuki Yasushi, Shimizu Yuko, Utsumi Hiroya, Fujihara Kazuo, Uchiyama Shinichiro, Suzuki Norihiro | 
| 発行年月 | 2012/08 | 
| 概要 | INTRODUCTION:Our study aim was to produce a Japanese translation of the 15-item Myasthenia Gravis Quality-of-Life Scale (MG-QOL15), assess its reliability and validity, and examine clinical factors affecting self-perceived QOL in MG.METHODS:We evaluated 327 consecutive patients with MG seen at six neurological centers. All patients completed the Japanese version of the MG-QOL15 (MG-QOL15-J), the Beck Depression Inventory-second edition (BDI-II), and a generic health-related QOL questionnaire, the SF-36. Disease severity was determined according to the Myasthenia Gravis Foundation of America (MGFA) quantitative MG score and the MG composite.RESULTS:The MG-QOL15-J exhibited adequate internal reliability, test-retest repeatability, and concurrent validity with SF-36, disease severity, and known-patient groups categorized by MGFA post-intervention status. Multivariate analysis revealed severity, dose of oral corticosteroids, and BDI-II as independent factors negatively affecting QOL.CONCLUSION:The MG-QOL15-J is anticipated to be a valuable clinical measure of QOL in Japanese patients with MG. | 
| DOI | 10.1002/mus.23398 | 
| PMID | 22806364 |